Sailong Pharmaceutical GroupLtd Balance Sheet Health
Financial Health criteria checks 3/6
Sailong Pharmaceutical GroupLtd has a total shareholder equity of CN¥528.7M and total debt of CN¥176.7M, which brings its debt-to-equity ratio to 33.4%. Its total assets and total liabilities are CN¥841.1M and CN¥312.4M respectively. Sailong Pharmaceutical GroupLtd's EBIT is CN¥5.2M making its interest coverage ratio 0.8. It has cash and short-term investments of CN¥68.5M.
Key information
33.4%
Debt to equity ratio
CN¥176.70m
Debt
| Interest coverage ratio | 0.8x |
| Cash | CN¥68.45m |
| Equity | CN¥528.67m |
| Total liabilities | CN¥312.41m |
| Total assets | CN¥841.08m |
Recent financial health updates
No updates
Recent updates
Some Shareholders Feeling Restless Over Sailong Pharmaceutical Group Co.,Ltd.'s (SZSE:002898) P/S Ratio
Oct 01
Impressive Earnings May Not Tell The Whole Story For Sailong Pharmaceutical GroupLtd (SZSE:002898)
Apr 26Subdued Growth No Barrier To Sailong Pharmaceutical Group Co.,Ltd. (SZSE:002898) With Shares Advancing 27%
Mar 08Financial Position Analysis
Short Term Liabilities: 002898's short term assets (CN¥274.9M) exceed its short term liabilities (CN¥249.0M).
Long Term Liabilities: 002898's short term assets (CN¥274.9M) exceed its long term liabilities (CN¥63.4M).
Debt to Equity History and Analysis
Debt Level: 002898's net debt to equity ratio (20.5%) is considered satisfactory.
Reducing Debt: 002898's debt to equity ratio has increased from 7.7% to 33.4% over the past 5 years.
Debt Coverage: 002898's debt is not well covered by operating cash flow (0.6%).
Interest Coverage: 002898's interest payments on its debt are not well covered by EBIT (0.8x coverage).